Product Information
DIPHENOXYLATE-ATROPINE 2.5-0.025 MG TABLET is a generic product labeled by Chartwell RX LLC, priced at $0.1386 per EA under NDC 62135061812. Its NADAC has been published 202 times since Oct 12, 2022.
FDA first approved this application on Oct 21, 2020. Its Orange Book therapeutic-equivalence code is AA.
The Low Outlier badge above means this manufacturer's average price in the Diphenoxylate hydrochloride and atropine sulfate market falls below Q1 − 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
DIPHENOXYLATE-ATROPINE 2.5-0.025 MG TABLET
Diphenoxylate hydrochloride and atropine sulfateStrength
.025; 2.5 mg/1; mg/1
Manufacturer
Chartwell RX LLCNDC
62135061812
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
ATROPINE SULFATE; DIPHENOXYLATE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA207128FDA Approved
10/21/2020
TE Code
AA
On Market Since
10/21/2020
Pharmacological Classes
Price Statistics
The NADAC for DIPHENOXYLATE-ATROPINE 2.5-0.025 MG TABLET has been published 202 times since Oct 12, 2022, and over the history we have for it it has declined 35.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1386 per EA |
|---|---|
| All-time high | $0.2446 (Apr 10, 2024) |
| All-time low | $0.1298 (Nov 20, 2024) |
| 52-week high | $0.1761 |
| 52-week low | $0.1371 |
| Median price | $0.1772 |
| Average price | $0.1769 |
| Largest weekly change | +55.5% (Aug 21, 2024) |
| Weeks tracked | 202 |
| Tracking since | Oct 12, 2022 |
1W
N/A
1M
N/A
3M
+0.2%
6M
-7.0%
1Y
-21.3%
3Y
-21.5%
5Y
N/A
All
-35.3%
Last surveyed Aug 19, 2026 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Diphenoxylate hydrochloride and atropine sulfate market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Chartwell RX LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Diphenoxylate hydrochloride and atropine sulfate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Anticholinergic class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of DIPHENOXYLATE-ATROPINE 2.5-0.025 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for DIPHENOXYLATE-ATROPINE 2.5-0.025 MG TABLET, manufactured by Chartwell RX LLC, is $0.1386 per EA (NDC 62135061812), effective Aug 19, 2026.
How has the price of DIPHENOXYLATE-ATROPINE 2.5-0.025 MG TABLET changed over time?
Over the history we have for it, the NADAC for DIPHENOXYLATE-ATROPINE 2.5-0.025 MG TABLET has declined 35.3%. It has been tracked across 202 weekly CMS publications since Oct 12, 2022.
What are the highest and lowest recorded NADAC prices for DIPHENOXYLATE-ATROPINE 2.5-0.025 MG TABLET?
Since Oct 12, 2022, the NADAC for DIPHENOXYLATE-ATROPINE 2.5-0.025 MG TABLET has ranged from a low of $0.1298 (Nov 20, 2024) to a high of $0.2446 (Apr 10, 2024), with a median of $0.1772 per EA.
Are there cheaper alternatives to DIPHENOXYLATE-ATROPINE 2.5-0.025 MG TABLET?
No other NADAC-published product currently shares the active ingredient and strength of DIPHENOXYLATE-ATROPINE 2.5-0.025 MG TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures DIPHENOXYLATE-ATROPINE 2.5-0.025 MG TABLET?
DIPHENOXYLATE-ATROPINE 2.5-0.025 MG TABLET (NDC 62135061812) is labeled by Chartwell RX LLC, and CMS classifies it as a generic product.